Lexicon Pharmaceuticals (NASDAQ:LXRX) Upgraded at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Leerink Partnrs in a note issued to investors on Tuesday, Zacks.com reports. Leerink Partnrs also issued estimates for Lexicon Pharmaceuticals’ Q1 2024 earnings at ($0.13) EPS, Q2 2024 earnings at ($0.13) EPS, Q3 2024 earnings at ($0.13) EPS, […]
Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) were up 11.1% on Wednesday . The stock traded as high as $2.23 and last traded at $2.20. Approximately 2,283,560 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 4,788,254 shares. The stock had previously closed at $1.98. […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $2.17, but opened at $2.32. Lexicon Pharmaceuticals shares last traded at $2.63, with a volume of 3,987,562 shares trading hands. Lexicon Pharmaceuticals Stock Performance The stock’s 50 day moving average price is […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) traded up 9.6% on Wednesday . The company traded as high as $3.26 and last traded at $3.21. 1,427,869 shares traded hands during trading, a decline of 63% from the average session volume of 3,826,041 shares. The stock had previously closed at $2.93. Lexicon Pharmaceuticals Stock Performance […]